Cardiol Therapeutics Inc.

Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.

CRDL | NDAQ

Overview

Corporate Details

ISIN(s):: CA14161Y2006
LEI:
Country:: United States of America
Address:: 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE
Website:: https://www.cardiolrx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of novel anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company develops treatments for underserved cardiovascular conditions, with a primary focus on pericarditis, myocarditis, and heart failure. Its lead product candidate, CardiolRx™, is an orally administered cannabidiol solution designed to target the underlying mechanisms of inflammation and fibrosis in cardiac disease. The company's pipeline also includes preclinical candidates. Cardiol Therapeutics collaborates with international research centers and clinical experts to advance its therapeutic programs for patients with debilitating heart conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardiol Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardiol Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Cardiol Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
TRAJANO Provides strategic consulting and innovative business solutions.	Spain	YTRA
Transgene Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.	France	TNG
TRANS GENIC GROUP INC. Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.	Japan	2342
Trevi Therapeutics, Inc. Clinical-stage biopharma developing an oral therapy for chronic cough in IPF and RCC.	United States of America	TRVI
TrueBlue, Inc. Provides staffing, recruitment, and workforce solutions for businesses in diverse sectors.	United States of America	TBI
True Data Inc. A big data platform offering consumer purchasing analytics from Japan's largest ID-POS data network.	Japan	4416
Tsubota Laboratory Incorporated Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.	Japan	4890
TWOSTONE&Sons Inc. An engineer platform providing IT talent and marketing services for corporate digital transformation.	Japan	7352
UJU Holding Limited AI-driven, full-link short-video marketing solutions for enterprises in China.	Hong Kong	1948
unerry,Inc. Transforms location data into actionable insights for retail and public sectors using AI.	Japan	5034